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STUDY QUESTION: Is sexual dysfunction associated with severity of semen quality impairment in men with couple infertility?
SUMMARY ANSWER: In males of infertile couples the prevalence of erectile dysfunction (ED) increases as a function of semen quality
impairment severity.
WHAT IS KNOWN ALREADY: Infertile men are at a higher risk for sexual dysfunction, psychopathological and general health disorders.
However, it has never been systematically investigated if these problems are associated with severity of semen quality impairment.
STUDY DESIGN, SIZE, DURATION: Cross-sectional analysis of a first-time evaluation of 448 males of infertile couples attending an out-
patient clinic from September 2010 to November 2015. In addition, 74 age-matched healthy, fertile men from an ultrasound study on male
fertility were studied for comparison.
PARTICIPANTS/MATERIALS, SETTING, METHODS: All subjects underwent a complete physical, biochemical, scrotal and flaccid
penile colour-Doppler ultrasound evaluation and semen analysis. Patients had already undergone at least one semen analysis; therefore, the
majority were aware of their sperm quality before taking part in the study. Validated tools, such as the International Index of Sexual Function-
15 (IIEF-15), Premature Ejaculation Diagnostic Tool (PEDT), Middlesex Hospital Questionnaire (MHQ), National Institutes of Health-
Chronic Prostatitis Symptom Index (NIH-CPSI), International Prostate Symptom Score and Chronic Disease Score (CDS), were used to
evaluate, respectively, sexual dysfunction, premature ejaculation (PE), psychopathological traits, prostatitis-like symptoms, lower urinary tract
symptoms and general health status.
MAIN RESULTS AND THE ROLE OF CHANCE: Among men with couple infertility, 96 showed azoospermia (Group #1), 245 at
least one sperm abnormality (Group #2) and 107 normozoospermia (Group #3). Fertile men were considered as a control group
(Group #4). After adjusting for age, we observed a higher prevalence of ED (IIEF-15-erectile function domain score <26) (18.3% versus
0%; P = 0.006) and PE (PEDT score >8) (12.9% versus 4.1%; P = 0.036) in males of infertile couples compared with fertile men. The ED
prevalence increases as a function of semen quality impairment severity (P < 0.0001), even after adjusting for confounders (age, CDS,
MHQ and NIH-CPSI total score), despite similar hormonal, glyco-metabolic and penile vascular status. Compared to fertile men, all
three groups of males with couple infertility showed a poorer erectile function, associated with an overall psychopathological burden
(MHQ total score), particularly with somatized anxiety (MHQ-S). Azoospermic men showed the worst erectile function and general
health: in this group, erectile function was negatively associated not only with psychopathological disturbances (MHQ total and MHQ-S
scores; P < 0.0001) but also with a less healthy phenotype (higher CDS; P = 0.015). In addition, azoospermic men reported higher PE
prevalence and lower sexual desire and orgasmic function when compared to fertile men (all P < 0.05), all of which were related to psy-
chopathological symptoms.
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LIMITATIONS, REASONS FOR CAUTION: The cross-sectional nature of the study represents its main limitation. A possible selection
bias concerning the control group of healthy, fertile men recruited into an ultrasound study might have occurred. Finally, causality cannot be
inferred in this type of study design and hence there should be some caution in interpreting the results.
WIDER IMPLICATIONS OF THE FINDINGS: Investigation of male sexual function, general health and psychological status in infertile
couples, especially if azoospermic, is advisable, in order to improve not only reproductive but also general and sexual health.
STUDY FUNDING/COMPETING INTEREST(S): Grants were received from the Ministry of University and Scientific Research (SIR
project to F.L., protocol number: RBSI14LFMQ). There are no conflicts of interest.
TRIAL REGISTRATION NUMBER: None.
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Introduction
Male infertility affects ~7% of all men (Krausz 2011; Giwercman and
Giwercman, 2013). Although sexual dysfunctions are rarely the cause
of male infertility (Krausz, 2011; Lotti et al., 2012), they are very fre-
quent in the general male population of reproductive age (Corona
et al., 2008, 2010a; McCabe et al., 2016).
So far, a few studies investigated erectile dysfunction (ED) and/or
premature ejaculation (PE) in infertile men using validated instruments
(Lotti et al., 2012; Gao et al., 2013). These studies reported a preva-
lence of ~18% and ~16% for ED and PE, respectively (Lotti et al.,
2012; Gao et al., 2013). Infertile patients with sexual dysfunction have
a higher prevalence of mood disturbances, such as anxiety and depres-
sive symptoms, when compared to infertile men without sexual pro-
blems or fertile subjects (Ferraresi et al., 2013; Bechoua et al., 2016).
However, the relationship between sexual dysfunction and the degree
of fertility impairment has never been investigated.
Interestingly, a decreased general health status is associated with
impaired male reproductive health (Salonia et al., 2009; Ventimiglia et al.,
2015; Eisenberg et al., 2015, 2016a,b). In addition, serious life-
threatening conditions such as atherosclerosis, metabolic syndrome and
diabetes are associated with testosterone deficiency, which is more
prevalent in subfertile males (Giwercman and Giwercman, 2013).
Hence, the concept that male infertility might represent an early marker
of poor general health is emerging. An early diagnosis of ED and the iden-
tification of its risk factors can provide useful information for stratifying
cardiovascular risk (Dong et al., 2011; Salonia et al., 2012; Yamada et al.,
2012; Vlachopoulos et al., 2013; Eisenberg et al., 2016a,b).
The aim of the present study is to investigate the relationship
between severity of semen quality impairment and sexual function in a
cohort of males of infertile couples. In addition, the data are compared
to those obtained in a healthy control group with proven fertility.
Materials andmethods
Patients
We studied a consecutive series of 448 male patients (mean ± SD age
36.8 ± 7.9 years) attending the outpatient clinic of the Sexual Medicine and
Andrology Unit of Florence (Italy) for the first time from September 2010
to November 2015, seeking medical care for couple infertility. All patients
studied routinely underwent a standard diagnostic protocol for males of
infertile couples (see below) and were invited to join the study, and the
resulting enrolment rate was 100%. Couple infertility was defined accord-
ing to the World Health Organization (WHO, 2000). Patients were
divided into three groups according to their sperm characteristics: azoo-
spermic (Group #1), subjects with at least one abnormality (value <5°
centile) in sperm concentration, progressive motility or sperm morphology
(Group #2) and normozoospermic (Group #3; all the aforementioned
sperm parameters ≥5° centile) according to WHO (2010). In Group #1,
subjects with sonographic evidence of bilateral absence of vas deferens
were considered as patients with obstructive azoospermia (OA).
As a control group (Group #4), we evaluated 74 age-matched
(mean ± SD age 36.2 ± 5.0 years) healthy, fertile men from a Florence
spin-off of an ultrasound study on male fertility sponsored by the European
Academy of Andrology (EAA; http://www.andrologyacademy.net/
studies.aspx), defined as healthy partners of a pregnant woman in the
second or third trimester of pregnancy or who fathered a child during the
last year, following natural conception. In particular, 116 subjects were
invited to join the study and the resulting enrolment rate was 64%.
All subjects were evaluated before beginning any treatment. The data
reported in this study for patients have been collected according to a ‘Day
Service’ standard protocol for males of infertile couples, encoded by
PACC L-99 (D/903/110 Azienda Ospedaliera-Universitaria Careggi
[AOUC], Florence, Italy) and approved by the Regional Health Care
Service (§DGRT n.1045; n.722; n.867), as previously described (Lotti
et al., 2014a). Data reported for the healthy, fertile subjects were collected
according to the EAA study protocol, approved by the Florence Ethical
Committee (6 June 2013; Prot.2013/0024124) and the AOUC (11
November 2013; Prot.37896/2013, Rubrica n.60/13). All subjects under-
went the following routine procedures: medical history, physical, biochem-
ical, scrotal and flaccid penile colour-Doppler ultrasound evaluation and
semen analysis. At the time of the first assessment, virtually all patients
with infertility problems were aware of their semen quality, which was sys-
tematically retested in our center. In addition, all subjects were invited to
complete self-administered validated questionnaires to evaluate sexual
function, prostatitis-like symptoms and psychological traits. All subjects
gave their written informed consent to have their clinical records included
in a dedicated database and they were aware that their data, after having
been made anonymous, would be used for clinical research purposes.
Physical examination and lifestyle
parameters
A complete andrological and physical examination, and self-reported data
on smoking, alcohol consumption behavior and physical activity were
assessed according to a previous study (Lotti et al., 2015).
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Table I Clinical, biochemical and seminal parameters of the subjects studied.
Males of infertile couples (n= 448) Group 4 (n= 74) P value
Group 1 (n = 96) Group 2 (n= 245) Group 3 (n = 107)
Clinical and laboratory parameters
Age (years) 36.1 ± 7.8 37.3 ± 7.8 36.3 ± 8.0 36.2 ± 5.0 0.421
Current smokers (%) 28.1 22.4 26.1 24.3 0.558
Current moderate-severe alcohol consumption (≥4 drinks/day), (%) 3.8 4.8 3.0 1.4 0.570
Current physical activity, (%) 40.0 50.9 57.3 55.4 0.095
Systolic blood pressure (mmHg) 123.4 ± 11.9 124.7 ± 14.8 123.7 ± 13.7 120.8 ± 10.5 0.193
Diastolic blood pressure (mmHg) 78.1 ± 8.4 79.6 ± 8.2 78.6 ± 8.3 79.3 ± 6.2 0.414
Waist circumference(cm) 97.6 ± 14.0 95.7 ± 12.2 94.5 ± 13.1 93.3 ± 10.1 0.137
History of cryptorchidism (%) 9.8 3.3 0 0 <0.0001
Mean testis volume (Prader) (ml) 16.0 ± 6.0 19.1 ± 4.4 20.9 ± 4.4 22.1 ± 4.0 <0.0001
Clinical varicocele (%) 28.1 35.7 36.8 24.7 0.187
History of genito-urinary infections (%) 27.6 27.7 29.6 18.9 0.415
LH (IU/l) 3.94 [2.85–6.62] 3.90 [2.86–5.40] 3.08 [2.20–4.40] 3.20 [2.20–4.45] <0.0001
FSH (IU/l) 7.30 [3.42–15.30] 5.32 [3.64–7.82] 3.38 [2.52–5.00] 3.35 [2.08–4.23] <0.0001
Total testosterone (nmol/l) 14.9 ± 7.1 15.4 ± 5.6 15.4 ± 6.0 16.2 ± 5.3 0.594
Calculated free testosterone (nmol/l) 0.308 ± 0.123 0.319 ± 0.103 0.324 ± 0.130 0.320 ± 0.092 0.827
SHBG (nmol/l) 31.4 ± 14.9 31.9 ± 13.7 31.9 ± 11.8 34.4 ± 14.4 0.510
PSA (ng/ml) 0.67 [0.43–0.93] 0.77 [0.52–1.06] 0.63 [0.40–0.95] 0.77 [0.49–0.99] 0.118
PRL (pmol/l) 180.0 [112.0–242.0] 158.0 [117.0–231.0] 159.0 [123.8–226.5] 160.0 [121.0–303.0] 0.991
TSH (mU/L) 1.65 [1.15–2.40] 1.71 [1.17–2.35] 1.88 [1.23–2.54] 1.49 [1.15–2.11] 0.282
Glycaemia (mmol/l) 5.11 ± 0.94 5.06 ± 0.72 4.94 ± 0.72 5.00 ± 0.61 0.400
Insulin levels 9.7 [6.0–16.2] 8.0 [6.0–12.1] 8.3 [5.7–12.8] 8.2 [5.8–11.9] 0.293
Total cholesterol (mmol/l) 4.83 ± 1.14 5.14 ± 0.93 5.12 ± 1.01 4.99 ± 0.90 0.110
HDL cholesterol (mmol/l) 1.25 ± 0.34 1.30 ± 0.33 1.25 ± 0.31 1.26 ± 0.31 0.455
LDL cholesterol (mmol/l) 12.95 ± 0.96 3.18 ± 0.81 3.17 ± 0.85 3.02 ± 0.82 0.159
Triglycerides (mmol/l) 1.17 [0.80–1.59] 1.19 [0.78–1.67] 1.26 [0.88–1.78] 1.20 [0.93–1.82] 0.646
Seminal parameters
Genetic abnormalities (%) 26 2.4 0.9 0 <0.0001
Sexual abstinence (days) 4.7 ± 3.4 4.3 ± 1.9 3.9 ± 1.6 4.3 ± 2.5 0.128
pH 7.3 ± 0.5 7.6 ± 0.2 7.6 ± 0.3 7.7 ± 0.2 <0.0001
Semen volume (ml) 2.5 ± 1.8 3.6 ± 1.8 3.2 ± 1.6 3.4 ± 1.4 <0.0001
Sperm concentration, x106/ml 0 9.0 [3.0–24.8] 52.0 [28.0–121.0] 70.0 [40.5–129.1] <0.0001
Sperm progressive motility (%) 30.2 ± 20.2 53.9 ± 11.4 58.1 ± 15.5 <0.0001
Sperm normal morphology (%) 2.0 [1.0–4.0] 7.0 [5.0–12.0] 7.0 [4.0–9.0] <0.0001
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Self-reported questionnaires
Patients were invited to complete several self-reported questionnaires,
including: International Index of Sexual Function-15 (IIEF-15), Premature
Ejaculation Diagnostic Tool (PEDT) National Institutes of Health-Chronic
Prostatitis Symptom Index (NIH-CPSI), International Prostate Symptom
Score (IPSS) and Middlesex Hospital Questionnaire (MHQ), according to
previous studies (Lotti et al., 2012, 2014b). The Chronic Disease Score
(CDS), an index of concomitant morbidities, was calculated as previously
described (von Korff et al., 1992).
Colour-Doppler ultrasound
All patients underwent scrotal and flaccid penile colour-Doppler ultra-
sound using the ultrasonographic console Hitachi H21 (Hitachi Medical
System, Tokyo, Japan) and a 7.5 MHz high-frequency linear probe (L54M
6–13 MHz) as previously reported (Corona et al., 2010b; Lotti et al., 2013;
Rastrelli et al., 2014; Lotti and Maggi, 2015).
Semen analysis and biochemical evaluation
All patients underwent semen analysis, performed according to the WHO
criteria (2010).
Biochemical parameters were assessed as previously reported (Lotti
et al., 2016).
Data analysis
Data were expressed as mean ± SD when normally distributed, as med-
ians (quartiles) for parameters with non-normal distribution, and as per-
centages when categorical.
For continuous parameters, one-way analysis of variance (ANOVA)
or Kruskal–Wallis test were used for comparisons of more than two
groups, and unpaired two-sided Student’s t-tests or Mann–Whitney U-
test for comparisons of two groups, for normally or non-normally dis-
tributed variables, respectively. Relative risk and 95% CI were calculated
for the association of categorical parameters, and chi-squared test was
used for comparisons. Subsequent multivariate analyses, adjusted for
age along with other confounders when specified, were performed with
analysis of covariance (ANCOVA) or binary logistic regression analysis
for continuous and categorical parameters, respectively. When distribu-
tion of non-normal parameters could be normalized through logarithmic
transformation, as in the case of NIH-CPSI total score, the same tests
were applied to logarithmically transformed data. A sensitivity analysis
was performed with continuity corrections for variables with zero
cases.
Moderator analyses were performed to clarify whether the relation-
ship between the IIEF-15-EFD and the CDS, the MHQ score and the
NIH-CPSI score changed according to semen quality impairment
severity. A moderator is a qualitative or quantitative variable that
affects the direction and/or strength of the relationship between an
independent or predictor variable and a dependent or criterion vari-
able. General linear model (GLM) was used to examine the moderating
role of seminal groups on IIEF-15-EFD and CDS, MHQ or NIH-CPSI
score interaction.
Statistical analyses related to the main outcomes of the present study,
i.e. ED and PE, were performed both including and excluding subjects with
OA or genetic abnormalities.
All statistical analysis was performed on SPSS (Statistical Package for the
Social Sciences, Chicago, IL, USA) for Windows 20.0. A P < 0.05 was con-
sidered as significant.
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Results
Among 448 consecutive males of infertile couples, 96 showed azoo-
spermia (Group #1), 245 at least one abnormality in sperm para-
meters (Group #2) and 107 normozoospermia (Group #3). In
particular, in Group #1 we found 12 subjects with sonographic evi-
dence of OA (bilateral absence of vas deference). In Group #2, 28
subjects showed isolated oligozoospermia, 19 isolated asthenozoos-
permia, 51 isolated teratozoospermia, 18 oligo-asthenozoospermia,
31 oligo-teratozoospermia, 20 astheno-teratozoospermia and 78
oligo-astheno-teratozoospermia. A cohort of 74 age-matched healthy,
fertile men was considered as a control group (Group #4). Table 1
reports the clinical characteristics of the sample. No differences in the
age and duration of infertility for male and female partners, as well as
in male lifestyle, were observed in groups #1–3 (Table 1). Genetic
abnormalities were detected in 31 men (6.9%), including 5 karyotype
abnormalities, 3 Y microdeletions and 23 vas deferens and/or seminal
vesicle agenesis. Genetic abnormalities were higher in Group #1 when
compared with groups #2 and #3 (Table 1). Statistical analyses related
to the main outcomes of the present study, i.e. ED and PE, were
performed both including and excluding subjects with OA or genetic
abnormalities (see below).
Considering Group #2, comparing subjects with isolated or multiple
sperm abnormalities, only mean testis volume (both at Prader and
ultrasound evaluation) was significantly different among subgroups,
being lower in oligo-astheno-teratozoospermic men and higher in sub-
jects with isolated asthenospermia as compared to the rest of Group
#2 sample (not shown). Conversely, no differences in other clinical,
biochemical, psychological and sexual parameters were observed
among subgroups (not shown), hence, Group #2 was considered as a
single category for statistical analysis.
Clinical and biochemical parameters
The reported frequency of cryptorchidism, at medical history,
increased as a function of semen quality impairment severity (Table 1
and Fig. 1, panel A). Accordingly, mean testis volume, as assessed by
Prader (Table 1) and ultrasound evaluation (Table 1 and Fig. 1, panel
B), decreased and gonadotrophin levels (Table 1 and Fig. 1, panels C–
D) increased, as a function of severity of semen quality impairment. In
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Figure 1 Comparison among groups of men for history of cryptorchidism, (panel A) mean testicular volume, (panel B) FSH (panel C) and LH
(panel D) levels. Groups #1–4 indicate: #1–3, males of infertile couples (#1, azoospermic; #2, males with at least one sperm abnormality; #3, normo-
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ated has been plotted for each group considered (#1–4). OR: odds ratio.
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particular, Group #1 showed higher prevalence of cryptorchidism,
lower mean testicular volume and higher gonadotrophins (all
P < 0.05), compared to groups #2, #3 and #4. In addition, in Group
#1, OA subjects showed higher mean testis volume and lower gona-
dotrophins (all P < 0.05) with respect to the rest of the azoospermic
sample, without significant differences in total or calculated free testos-
terone levels (not shown).
No other significant differences in hormonal, glyco-metabolic and
clinical parameters (including flaccid penile peak systolic velocity and
acceleration) were observed among the groups (Table 1).
Psychological traits
MHQ results were available for 516 men (98.8%). Overall, MHQ total
score, an index of mood and anxious psychopathology, increased as a
function of severity of semen quality impairment (Fig. 2, panel A).
Accordingly, somatized anxiety (MHQ-S), free-floating anxiety (MHQ-
A) and depressive symptoms (MHQ-D) scores decreased from Group
#1 to #4 (Fig. 2, panels B–D).
Prostatitis-like symptoms
NIH-CPSI and IPSS results were available for 516 (98.8%) and 510
(97.7%) men, respectively. At ANCOVA, after adjusting for age, NIH-
CPSI total or subdomains (pain and quality of life) scores were signifi-
cantly lower in Group #4 when compared to the rest of the sample
(Fig. 3, panels A–C). Conversely, no difference in IPSS total score was
observed (not shown).
Chronic disease score
CDS was significantly different among the groups (Fig. 3, panel D),
being higher in Group #1 when compared to the rest of the sample,
even after adjusting for age (Group #1 = 0.9 ± 2.5 versus groups #2–
4 = 0.3 ± 1.1; F = 13.5, P < 0.0001). Accordingly, Group #4 showed
the lowest prevalence of men with CDS > 0 when compared to the
rest of the sample (Group #4 = 6.8% versus #1–3 = 16.1%,
P = 0.022), even after adjusting for age (odds ratio (OR) = 0.39 [0.15–
0.99], P = 0.049).
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Sexual function
IIEF-15 results were available for all the subjects studied. Among males
of infertile couples, 82 (18.3%) reported ED (IIEF-15-EFD score <26).
In particular, 53 patients (11.8%) had mild, 16 (3.6%) mild to moder-
ate, 8 (1.8%) moderate and 5 (1.1%) severe ED. Conversely, none of
the fertile subjects had ED. After adjusting for age, the prevalence of
any ED was higher in males of infertile couples compared with fertile
men (OR = 0.06 [0.01–0.46], P = 0.006).
A significant difference in the prevalence of any kind of ED was
observed among groups (Fig. 4, panel A). In particular, Group #1
showed the highest and Group #4 the lowest prevalence of ED, even
after adjustment for age (not shown). Similar results were observed
when subjects with IIEF-15-EFD score <22 were considered
(OR = 0.30 [0.17–0.56], P < 0.0001). Accordingly, IIEF-15 total and
EFD scores decreased as a function of semen quality impairment
severity (Fig. 4, panels B–C), with EFD score being the lowest in
Group #1 and highest in Group #4 (not shown). The differences in
ED and IIEF-15-EFD score among groups were confirmed after adjust-
ment for age, CDS, MHQ and NIH-CPSI total score (OR = 0.55
[0.39–0.77], P < 0.0001 and F = 5.5, P = 0.001, respectively). Similar
results were observed when subjects with OA (OR = 0.57 [0.40–
0.81], P = 0.002 and F = 3.87, P < 0.01, for ED prevalence and IIEF-
15-EFD score, respectively) or genetic abnormalities (OR = 0.58
[0.41–0.84], P = 0.003 and F = 3.69, P < 0.02, for ED prevalence and
IIEF-15-EFD score, respectively) were excluded from the analysis.
After adjusting for age, Group #1 showed lower scores in sexual
desire (7.4 ± 1.4 versus 7.9 ± 1.4; F = 4.20, P < 0.05) and orgasmic
function (8.9 ± 2.1 versus 9.5 ± 1.1; F = 4.67, P < 0.05) IIEF-15 subdo-
mains when compared to Group #4. No differences in intercourse and
overall sexual satisfaction were observed among groups (not shown).
Ejaculatory function
PEDT results were available for 519 men (99.4%). According to PEDT
score, 58 males of infertile couples (12.9%) reported PE: 26 (5.8%)
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‘probable PE’ (PEDT score 9–10) and 32 (7.1%) ‘overt PE’ (PEDT
score ≥11). Among fertile subjects, three reported PE: 1 (1.4%) prob-
able PE and 2 (2.7%) overt PE. After adjusting for age, the prevalence
of any PE was lower in fertile men than in patients of infertile couples
(OR = 0.28 [0.09–0.92], P = 0.036). The highest prevalence of any PE
was observed in Group #1, which was significantly different from
Group #4 (Fig. 4, panel D). Similar results were observed when sub-
jects with OA or genetic abnormalities were excluded from the ana-
lysis (not shown).
Moderator analysis
We evaluated whether the relationship among IIEF-15-EFD score and
CDS, MHQ and NIH-CPSI scores would change as a function of sever-
ity of semen quality impairment. Accordingly we estimated the moder-
ation effect of being in the different seminal groups on the interaction
of IIEF-15-EFD with other variables, including CDS, MHQ and NIH-
CPSI (GLM). We used the moderator analysis, which allows for the
identification of subpopulations of subjects in whom a specific
relationship between two variables is more likely. IIEF-15-EFD score
was negatively associated with CDS (r = −0.158, P < 0.0001), MHQ
(r = −0.300, P < 0.0001) and NIH-CPSI total score (r = −0.174,
P < 0.0001) as well as with age (r = −0.152, P = 0.001). The relation-
ship between IIEF-15-EFD score and CDS or MHQ, but not NIH-
CPSI, score, was differentially moderated by different seminal groups,
according to the GLM (Fig. 5, panels A–D). IIEF-15-EFD was found to
be associated with MHQ total score in groups #1, #2 and #3, but not
in #4 (Fig. 5, panel A). Considering MHQ subdomains, similar associa-
tions were verified only for MHQ-S (Fig. 5, panel B). In addition, GLM
revealed significant interactions between CDS and categorization into
seminal groups on IIEF-15-EFD score. IIEF-15-EFD was found to be
associated with CDS in Group #1,but not in the other groups (Fig. 5,
panel C). Conversely, the relationship between IIEF-15-EFD and NIH-
CPSI total score was not moderated by different seminal groups
(Fig. 5, panel D; data not shown). Similar results were observed when
subjects with OA were excluded from the analyses (not shown).
In addition, GLM revealed significant interactions between MHQ-D
score and categorization into seminal groups (MHQ-D score * Group
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#1 versus #4: F = 4.3, P = 0.015, adjusted for age, CDS, NIH-CPSI
total score, MHQ-A and MHQ-S scores) on sexual desire subdomain
score, as sexual desire was found to be associated with MHQ-D score
in Group #1 (β = −0.314, P = 0.016), but not in Group #4
(β = −0.186, P = 0.166). In a similar model, GLM revealed significant
interactions between MHQ-S score and categorization into seminal
groups (MHQ-S score * Group #1 versus #4: F = 7.1, P = 0.01,
adjusted for age, CDS, NIH-CPSI total score, MHQ-A and MHQ-D
scores) on orgasmic function subdomain score, as orgasmic function
was found to be associated with MHQ-S in Group #1 (β = −0.354,
P = 0.009), but not in Group #4 (β = −0.209, P = 0.150).
Finally, GLM revealed a significant interaction between MHQ total
score and categorization into seminal groups (MHQ total score *
Group #1 versus #4: F = 7.4, P = 0.001, adjusted for age, CDS and
NIH-CPSI total score) on PE, as PE was found to be associated with
MHQ total score in Group #1 (OR = 1.09 [1.02–1.16], P = 0.013),
but not in #4 (OR = 1.04 [0.94–1.15], P = 0.473).
Similar associations were observed when subjects with OA or gen-
etic abnormalities were excluded from the analysis (not shown).
Discussion
This is the first study investigating the association between the severity
of the infertility condition and sexual dysfunction in males of infertile
couples, comparing results with those of a control group of healthy,
fertile subjects of similar age. We essentially found that having semen
impairment exerts a negative effect not only on fathering but also on
male sexuality. In particular, ED prevalence increases as a function of
severity of semen quality impairment, despite similar hormonal (includ-
ing testosterone), glyco-metabolic and penile vascular status of the
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Figure 5 Associations between IIEF-15-erectile function domain (EFD) score and psychopathological traits, CDS or prostatitis-like symptoms in
groups of men with different severity of semen quality impairment, according to moderator analysis. Associations, in groups with different severity of
semen quality impairment, of erectile function (IIEF-15-EFD score) with: overall psychopathological symptoms (MHQ total score) (panelA); somatized
anxiety (MHQ-S) subdomain score (panel B); CDS (panel C); NIH-CPSI total score (panel D). Tables show F and p value of the interactions between
moderator variables (comparison between groups with different severity of semen quality impairment) and MHQ total score, MHQ-S subdomain
score and CDS, in a moderator analysis adjusted for confounders considering as dependent variable the IIEF-15-EFD score. Accordingly, associations
between IIEF-15-EFD score and the aforementioned parameters in different seminal groups are shown. Because the relationship between IIEF-15-EFD
and NIH-CPSI total score was not moderated by different seminal groups, no Table is reported in panel D. ° adjusted for age, NIH-CPSI total score
and CDS; °° adjusted for age, NIH-CPSI total score, CDS, MHQ-A and MHQ-D scores; °°° adjusted for age, NIH-CPSI and MHQ total scores. MHQ,
Middlesex Hospital Questionnaire; A, free-floating anxiety; S, somatized anxiety; D, depressive traits; IIEF-15, International Index of Erectile Function-
15; NIH-CPSI, National Institute of Health-Chronic Prostatitis Symptom Index; GLM, general linear model. Groups #1–4 indicate: #1–3, males of
infertile couples (#1, azoospermic, red circles and lines; #2, males with at least one sperm abnormality, orange circles and lines; #3, normozoosper-
mic, green circles and lines); #4, fertile men (blue circles and lines). The circle size reflects the number of observations.
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different groups. Compared to fertile subjects, all males with couple
infertility showed a poorer erectile function closely associated with an
increased psychopathological burden, particularly with somatized anx-
iety. Azoospermic men showed the worst sexual function and general
health, with psychopathological traits and a less healthy phenotype
being the most important factors underlying ED. In this group, ejacula-
tory latency, sexual desire and orgasmic function were reduced with
respect to fertile men, and mainly associated with mood disturbances.
In our cohort, ED prevalence is in agreement with previous reports
on infertile men (Lotti et al., 2012; Gao et al., 2013). Erectile function
decreased in a stepwise fashion as a function of severity of semen qual-
ity impairment, although ED-related hormonal, glyco-metabolic and
penile vascular parameters were not different among seminal groups.
Despite this evidence, a less healthy phenotype, as assessed by CDS,
was observed in infertile men, being the worst in the azoospermic
group. In addition, only in the azoospermic group was CDS associated
with ED. It can be speculated that the relatively young age of our
cohort, with a limited duration of any underlying diseases, might
explain the lack of difference observed in ED-related parameters des-
pite a stepwise increase in CDS as a function of semen quality impair-
ment. Accordingly, men with couple infertility have a higher rate of
cancerous (Raman et al., 2005; Walsh et al., 2010; Eisenberg et al.,
2013) and noncancerous (Salonia et al., 2009) conditions than age-
matched males of the general population or fertile men. In addition,
in line with our data, a relationship between a decreased general
health and sperm abnormalities has been previously reported
(Eisenberg et al., 2015; Ventimiglia et al., 2015). Our data add new
insights to this field. ED is a well-known risk factor for cardiovascular
diseases in the general population (Dong et al., 2011; Yamada et al.,
2012; Vlachopoulos et al., 2013). We suggest that the presence of
ED in infertile—particularly in azoospermic—men, might alert physi-
cians to evaluate possible subclinical underlying morbidities.
Whether or not ED in infertile subjects might represent an earlier
marker of forthcoming cardiovascular diseases would need further
studies.
As expected, azoospermic men had a higher prevalence of crypt-
orchidism, lower mean testicular volume and higher gonadotrophins,
compared to the other groups of patients (#2 and #3) and controls
(#4), but testosterone levels were similar. Of note, we observed a
slightly decreased testis volume and only moderately increased
gonadotrophin levels with normal testosterone, while other studies
reported different clinical or hormonal characteristics in azoospermic
men (Wosnitzer et al., 2014; Bobjer et al., 2016). This may depend on
the patient characteristics of the cohort investigated. For example, a
higher prevalence of OA patients (without sonographic evidence of
bilateral absence of vas deferens) or of subjects with maturation arrest
might explain the different results (Wosnitzer et al., 2014). Hormonal
findings indicate a frequent condition of compensated hypogonadism
in azoospermic men. It has been hypothesized that compensated male
hypogonadism represents a milder form of hypogonadism potentially
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associated with neurological, psychological and cardiovascular distur-
bances, including alterations of bone metabolism and glycolipid profile
(Giannetta et al., 2012; Bobjer et al., 2016). In subjects with sexual dys-
function (Corona et al., 2014) and in the general population (Tajar
et al., 2010), those with compensated hypogonadism more often
report mood impairment, including higher somatized anxiety and
depressive symptoms, when compared to eugonadal patients. A pos-
sible explanation is that the testosterone threshold to maintain
adequate mood level is lower than for other testosterone-dependent
functions (Corona et al., 2014).
In our cohort, psychopathological traits increase in a stepwise fash-
ion as a function of semen impairment. We found, for the first time,
that erectile function is negatively associated with somatized anxiety,
which was highest in azoospermic men. Somatized anxiety is the
unconscious process by which psychological distress is expressed as
physical symptoms (APA, 2013). It is well known that infertile men
may develop feelings of inadequacy, guilt, depression, distress, anxiety
(Ferraresi et al., 2013; Bechoua et al., 2016), low virility, low self-
esteem (Owens, 1982; Gannon et al., 2004) and psychological pres-
sure resulting from sex aimed at conception (Monga et al., 2004; Song
et al., 2015). Accordingly, the announcement of azoospermia has been
described as ‘the worst news ever received’ (Johansson et al., 2011).
Infertility per se and related psychological problems, including anxiety,
are associated with sexual dysfunction, including ED (Berger, 1980;
Marci et al., 2012; Ferraresi et al., 2013; Bechoua et al., 2016).
The prevalence of PE observed in the present study is similar to
what has been reported in the general population (McCabe et al.,
2016). Azoospermic men showed a higher PE frequency when com-
pared to fertile men, associated with psychopathological alterations, in
line with a previous study (Gao et al., 2013). The relationship between
anxiety (Lotti et al., 2012; Zhang et al., 2013a; Gao et al., 2014) or
depression (Son et al., 2011; Gao et al., 2013; Zhang et al., 2013a,b;
Gao et al., 2014) and PE has been previously reported.
Azoospermic men also showed lower sexual desire and orgasmic
function when compared to fertile men. Previous studies reported that
hypoactive sexual desire is more prevalent in infertile men
(Ramezanzadeh et al., 2006; Smith et al., 2009) than in the general popu-
lation (Laumann et al., 1999; Corona et al., 2013, 2016). This has been
related to the loss of spontaneity of sexual intercourse, deprived of its
recreative value and subordinated to pregnancy (Cousineau and
Domar, 2007). It could be speculated that azoospermic men, aware
that the sexual act cannot lead to pregnancy (‘firing blanks’), experience
both depressive symptoms and somatic anxiety, related to decreased
sexual desire and orgasmic function, respectively, along with ED.
Our study has some limitations. First, due to the cross-sectional
nature of the study, no causality hypothesis can be inferred. In add-
ition, a possible selection bias concerning the control group of
healthy, fertile men might have occurred. Hence, caution is advisable
in interpreting the results. Furthermore, in the CDS, some of the
agents described are no longer commonly prescribed, while newer
agents for treating the conditions are not listed, and chronic infec-
tions are not represented. Of note, the trend of CDS in different
seminal groups is more heterogeneous than those observed for
other endpoints. Hence, results derived from CDS must be consid-
ered with caution.
Another limitation is that the results obtained can be considered
biased by the participants knowing their fertility status. Considering
that our unit represents a second-level fertility center, patients con-
sulting for couple infertility for the first time usually had already under-
gone at least one semen analysis. Hence, the majority of patients
evaluated in our study were aware of their sperm quality. Even fertile
subjects were aware of their fertile status, by definition. Although
responses to inventories could be systematically biased by knowing
their fertility status, they reflect the real emotions and feelings of
subjects.
Finally, data observed in azoospermic men were confirmed after
excluding subjects with genetic abnormalities from the statistical ana-
lysis. Hence, psychological symptoms and sexual dysfunctions seem to
be related to the diagnosis of azoospermia, rather than a consequence
of the underlying genetic diseases (Corona et al., 2010c; Towns, 2010;
Quittner et al., 2016).
Conclusions
ED increases as a function of severity of semen quality impairment,
independently of physical, biochemical and vascular parameters, and is
associated with mood disturbances. Azoospermic men reported the
worst erectile function and general health status, closely related to
somatized anxiety. In addition, they also had higher PE, lower sexual
desire and poorer orgasmic function, all of which were related to psy-
chopathological symptoms. Investigation of sexual function, general
health and psychological status of males of infertile couples, especially
if azoospermic, is advisable, to improve not only reproductive but also
general and sexual health.
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